...
机译:中草药对氯吡格雷和阿司匹林双抗血小板治疗的影响:药代动力学和药效学结果及大鼠相关机制
Chinese Univ Hong Kong Fac Med Sch Pharm Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Fac Med Sch Pharm Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Fac Med Sch Pharm Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Fac Med Sch Pharm Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Fac Med Sch Pharm Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Fac Med Dept Inst Integrat Med Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Fac Med Dept Med &
Therapeut Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Fac Med Dept Med &
Therapeut Shatin Hong Kong Peoples R China;
Chinese Univ Hong Kong Fac Med Sch Pharm Shatin Hong Kong Peoples R China;
Aspirin; Clopidogrel; Dual antiplatelet therapy; Traditional Chinese medicine; Pharmacokinetics; Pharmacodynamics; Herb-drug interactions;
机译:中草药对氯吡格雷和阿司匹林双抗血小板治疗的影响:药代动力学和药效学结果及大鼠相关机制
机译:随机临床试验比较Longterm Clopidogrel VS Aspirin单药治疗药物洗脱冠状动脉植入后的双抗血小板治疗:冠状动脉狭窄 - 延伸抗血小板单药治疗(Host-rese)试验的设计与理由。
机译:使用P2Y12即时检测在STEMI接受原发PCI的患者中对新的双重抗血小板疗法(阿司匹林,普拉格雷)和三重抗血小板疗法(阿司匹林,氯吡格雷,西洛他唑)进行随机比较
机译:口腔抗凝治疗个性化的药代动力学药效模型
机译:提议中美就中成药数字基础设施进行合作。
机译:量身定制的抗血小板治疗可以克服氯吡格雷和阿司匹林的抗药性-BOchum氯吡格雷和阿司匹林计划(BOCLA-Plan)可改善抗血小板治疗
机译:双抗血小板治疗对阿司匹林和氯吡格雷对急性,非肠道脑卒中阿司匹林单药治疗的比较效果